Pomalidomide as an Immune-enhancing Agent for the Control of HIV
Pomalidomide as an Immune-enhancing Agent for the Control of HIV
Active, not recruiting · NCT06660498 · Registry updated 2026-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pomalidomide as an Immune-enhancing Agent for the Control of HIV | HIV-1 Infection | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-07 | NCT06660498 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Aarhus | 259 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aarhus University Hospital | Aarhus | Denmark | 77 |
| Royal Melbourne Hospital | Melbourne | Australia | 5 |